# Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus — retained record

> Retained news record from news:seeking-alpha.

Canonical: https://highsignal.app/data/records/96eb81506603dd45

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:seeking-alpha)  published 2026-06-28 13:05 ingested 2026-06-28 13:40

[original source ↗](https://seekingalpha.com/news/4607843-notable-healthcare-headlines-for-the-week-merck-abbvie-and-bayer-in-focus?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news)

## retained text



```
Search fieldHome page Seeking Alpha - Power to InvestorsAbout PremiumCreate free accountSearch for Symbols, analysts, keywordsLog in

On the Move

Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus

Jun 28, 2026, 9:05 AM ETState Street Health Care Select Sector SPDR ETF (XLV)INCY, PFE, BSX, ALGN, CRL, DXCM, TECH, ABBV, ZTS, IQVBy : Harsh Shukla, SA News Editor

Copy LinkSavePlay( 7min )

Comments

Wall Street's major indexes ended lower on Friday as the technology sector continued its selloff after mounting concerns over elevated AI-related valuations and OpenAI considering pausing its IPO until 2027.

The benchmark S&P 500 closed down 0.1%, while the Nasdaq Composite ended 0.2% lower, and

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below

Quick Insights

Healthcare sector surged due to major M&A activity and positive Supreme Court ruling, leading to outsized gains for several healthcare stocks.

Bio-Techne shareholders benefit from a 36% premium deal price; transaction is expected to be accretive post-closing and may yield long-term gains.

The ruling reduces Bayer's litigation costs and dismisses many claims, strengthening positions for companies facing similar legal challenges.

Recommended For You
```



document fetched 2026-06-28 13:40 · canonical https://seekingalpha.com/news/4607843-notable-healthcare-headlines-for-the-week-merck-abbvie-and-bayer-in-focus?feed_item_type=news